Jyoti D. Patel, MD | Authors

Articles

Cediranib Versus Olaparib in Recurrent Platinum-Sensitive Ovarian Cancer

September 25, 2014

Article

Jyoti D. Patel, MD, discusses a phase II trial that looked at olaparib in combination with cediranib versus olaparib alone in recurrent platinum-sensitive ovarian cancer.

Early Treatment With Docetaxel for Metastatic Prostate Cancer

July 24, 2014

Video

Jyoti D. Patel, MD, ASCO expert, associate professor, Northwestern University Feinberg School of Medicine, discusses the early treatment of patients with metastatic prostate cancer.